SlideShare a Scribd company logo
1 of 61
Presenter: Dr Abdulaziz N .(Year II resident)
Moderator: Dr Jemal (Ass. Professor of gyneobs )
2/8/2024 Seminar presentation on FGR 1
Outline
 Objective
Introduction
Definition and pattern of FGR
Etiologies of FGR
Diagnostic Tools in FGR
Screening And prevention
Management of FGR
Selective FGR
References
2/8/2024 Seminar presentation on FGR
Objectives
To discuss on definition and Diagnosis FGR
To discuss on Etiologies and risk factors FGR
To discuss on methods of screening and prevention of FGR
To discuss current on recommendations on management of
FGR
To discuss on Diagnosis and management of selective FGR
2/8/2024 Seminar presentation on FGR
Introduction
Fetal growth may be divided into three phases
phase of hyperplasia ( First 16 weeks )
Phase of cellular hyperplasia and hypertrophy ( 16-32
weeks)
Phase of cellular hypertrophy (After 32 weeks )
Eighty percent of fetal fat gain is accrued after 28 weeks’
gestation
2/8/2024 Seminar presentation on FGR 4
Cont…
Fetal development is believed to be determined by
maternal provision of substrate and its placental
transfer, whereas fetal growth potential is governed by
the genome.
FGR is defined as the failure of the fetus to meet its
growth potential due to a pathological factor.
2/8/2024 Seminar presentation on FGR 5
Cont…
FGR is the second leading cause of PNM (6-10x ) next to
prematurity
53% of preterm stillbirths and 26% of term stillbirths have
FGR.
The incidence of intrapartum asphyxia may be as high as
50%
2/8/2024 Seminar presentation on FGR 6
Definition and pattern of FGR
From the 1960s, growth has been classified by the
absolute birth weight as ;
LBW; <2500 g
VLBW; < 1500 g
ELBW; <1000 g
macrosomia > 4000 g
subsequently, studies demonstrated only the comparison
actual birthweight with GA, associated with high risk.
2/8/2024 Seminar presentation on FGR 7
Cont…
This resulted in the currently accepted classification of birth
weight as;
very small for gestational age (VSGA; <3rd percentile),
small for gestational age (SGA; <10th percentile),
 Average for gestational age (AGA; 10th to 90th percentile), or
 Large for gestational age (LGA; >90th percentile).
2/8/2024 Seminar presentation on FGR 8
ETIOLOGIES AND RISK
FACTORS FGR
Maternal
Fetal
 Hypertensive Disease
 Pregestational diabetes
 Cyanotic cardiac disease
 Autoimmune disease
 Restrictive pulmonary disease
 High altitude
 Substance abuse
 Malabsorbative disease
 Malnutrition
 Multiple gestation
 Teratogenic exposure
 Fetal infection
 Genetic Disorders
 Structural abnormalities
placental
 Primary placental disease
 Placental abruption and ind
infarction
 Placenta previa
 Placental mosaicism
2/8/2024 Seminar presentation on FGR 9
Diagnostic Tools in FGR
 Accurate gestational age assessment is critical for determining whether
birth weight is normal.
 Symphysis–fundal height
 A single SFH at 32-34ks has 65-85 %
sensitivity and 96% specificity
 The overall sensitivity of serial fundal height to detect FGR ranges
from 11 to 25 % .
 Detection rates are lower in obese women
2/8/2024 Seminar presentation on FGR 10
Diagnostic Tools in FGR
Fetal Biometry
SEFW- most important calculated US variable
BPD-alone is a poor tool for the detection of FGR
HC
TCD
AC-single best measurement for the detection of FGR
HC/AC -70% to 85% FGRs detected
FL/AC ≥ 23.5 suggests FGR
2/8/2024 Seminar presentation on FGR 11
Diagnostic Tools….
Fetal Anatomic Survey
Amniotic Fluid Assessment -Placental dysfunction and fetal
hypoxemia both may result in decreased perfusion of the fetal
kidneys.
2/8/2024 Seminar presentation on FGR 12
Diagnostic Tools…
Doppler Velocimetry –
 serves as a diagnostic as well as a monitoring tool
 Arterial Doppler waveforms provide information on
downstream vascular resistance.
 S/D ratio, the resistance index, and the pulsatility index (PI) are
the three Doppler indices most widely used
 Venous Doppler parameter Provide assessment of cardiac
forward function
2/8/2024 Seminar presentation on FGR 13
Umbilical Artery Flow-Velocity
Waveforms
►Normal
►Decreased EDF; Indices
become affected when 30% of
placental bed obliterated
►AEDF-when 50% of placental
bed obliterated
►REDF-when ≥70% of
placental bed obliterated
2/8/2024 Seminar presentation on FGR
Cont…
Invasive Testing
maternal serology and/or viral polymerase chain reaction (PCR)
Invasive fetal testing can be performed to obtain amniotic fluid
and/or fetal blood for karyotyping or microarray analysis
2/8/2024 Seminar presentation on FGR 15
Fetal Growth Restriction Dx
Various criteria has been used to define FGR. Included;
EFW below the 3rd, 5th, or 10th percentiles ;
Similar abdominal circumference (AC) percentiles;
A specified decline in the EFW percentile or AC percentile over
serial assessments; and
Various abnormal Doppler findings
2/8/2024 Seminar presentation on FGR 16
Diagnosis
SMFM-ACOG-AIUM ISUOG
AC or EFW <10th centile
for GA
Early (<32 weeks) Late (≥32 weeks)
AC or EFW <3rd centile for
GA or UA-AEDF
or
AC or EFW <10th centile
Combined with one of the
following:
a) UtA PI >95th centile
b) UA-PI >95th centile
AC or EFW <3rd centile for
GA
or
Any two of the following:
a) AC or EFW <10th centile
for GA
b) AC/EFW crossing centiles
>2 quartiles on growth
centiles
c) CPR <5th centile or UA-PI
>95th centile
2/8/2024 Seminar presentation on FGR 17
Cont..
SMFM criteria had higher sensitivity than the ISUOG criteria for
the prediction of neonatal SGA (54.7% vs 28.8%) but had a
higher false-positive rate (6.7% vs 1.6%).
The positive predictive value for the prediction of neonatal
morbidity was poor for both definitions (15.3% vs 25.5%)
SMFM criteria offers a more simple, straightforward and
pragmatic approach to the diagnosis of FGR, that also has
the ability to identify more at-risk pregnancies.
2/8/2024 Seminar presentation on FGR 18
Cont…
Early Onset FGR Late Onset FGR
 <32 weeks
 prevalence of 0.5%_1%
 Strong association with PE
 Predictable natural course
 Main challenge is management
 ≥ 32 weeks
 5%_10%
 Less likely associated with PE
 Main challenge is diagnosis
 Natural course is less
predictable and there is a risk
of sudden decompensation And
stillbirth.
2/8/2024 Seminar presentation on FGR 19
Which growth chart should should be
used
Growth references vs growth standards
Charts based on birth weight vs SFWE
Universal versus customized charts
2/8/2024 Seminar presentation on FGR 20
Comparison of the 10th
percentile curves of common
growth charts.
Diagnostic Algorism
2/8/2024 Seminar presentation on FGR 21
Screening And prevention
FGR as a disease entity fulfills several criteria that potentially
justify a screening program.
 Maternal History
poor pregnancy outcome (spontaneous abortions , neonatal
and intrauterine deaths)
 25 % risk of recurrence after 1 FGR.
 After 2 pregnancies the risk increased by 4 fold.
2/8/2024 Seminar presentation on FGR 22
Maternal serum analytes
Serum estriol, human placental lactogen , hCG and MSAFP in
2nd Triminister .
Elevated MSAFP and hCG levels in the 2nd trimester are
considered markers of abnormal placentation.
Associated with increased risk of FGR
Single, unexplained elevated value of 2 to 2.5 MoM raises the
risk 5-fold to 10-fold.
2/8/2024 Seminar presentation on FGR 23
Cont…
A decrease in PAPP-A or the PlGF shown the most consistent
predictive performance in 1st triminister.
They associated with early abnormalities in placental
angiogenesis and development
 A decrease in the PAPP-A to less than 0.8
MoM is a risk for subsequent placental dysfunction
2/8/2024 Seminar presentation on FGR 24
Cont…
 Clinical Examination
After 20 weeks’ gestation, a lag of the SFH ≥4 cm
signifies FGR
Is the only screening tool recommended
 Maternal Doppler Velocimetry
Abnormal uterine artery flow-velocity waveforms
 Integrated Approach
2/8/2024 Seminar presentation on FGR 25
prevention
Efforts to prevent FGR have been disappointing
Life style modification
Low-dose aspirin has been extensively evaluated as a possible
preventive agent for placental dysfunction.
Only starting aspirin before 16 weeks’ gestation derive a 50% to
60% reduction in the RR for development of preeclampsia or
FGR.
2/8/2024 Seminar presentation on FGR 26
Cont…
Elimination of contributors such as stress, smoking, and alcohol
and drug use .
 Bed rest in the left lateral decubitus position to increase
placental blood flow.
Dietary supplementation may be helpful in those with poor
weight gain or low pre pregnancy weight
2/8/2024 Seminar presentation on FGR 27
Cont…
Maternal hyper oxygenation
can raise the fetal cord blood pO2
fetal growth velocity was not improved
 Maternal hyper alimentation
Maternal volume expansion
Corticosteroids for enhancing lung maturation and preventing
IVH when delivery is anticipated before 34 weeks’ gestation
2/8/2024 Seminar presentation on FGR 28
Risk Assessment and Screening for
FGR
2/8/2024 Seminar presentation on FGR 29
Assessment of fetal well-being
The institution of antenatal surveillance is a critical component
in the management of the growth-restricted fetus.
The goal is to avoid stillbirth and optimize the timing of
delivery,
The likelihood of fetal acidemia and stillbirth is the strongest
fetal criterion for delivery.
Incontrast, gestational age–specific expectations for neonatal
complications and survival force conservative management.
2/8/2024 Seminar presentation on FGR 30
Cont…
 Antenatal surveillance tests need to predict fetal acid-base
status, rate of anticipated progression, and the resulting risk
for deterioration and stillbirth.
The monitoring tools available to achieve this include NST ,
CST, BPP and Doppler studies.
2/8/2024 Seminar presentation on FGR 31
Cont…
 Maternal Monitoring of Fetal Activity
Fetal activity charting in pregnancies complicated by FGR
predicts subsequent distress in labor.
 Fetal Heart Rate Analysis
Normal FHR characteristics are determined by gestational age,
maturational and functional status of central regulatory centers,
and oxygen tension
2/8/2024 Seminar presentation on FGR 32
Cont…
Reactive NST indicates absence of fetal acidemia at the moment
of the FHR recording
Correlates highly with a fetus not in immediate danger of
intrauterine demise
Nonreactive NST results, on the other hand, are often falsely
positive and require further evaluation
The CST is an additional option for testing placental respiratory
reserve
2/8/2024 Seminar presentation on FGR 33
Cont…
 Amniotic Fluid Volume
 Assessment of AFV provides an indirect measure of vascular
status
Interventions based on twice-weekly MBPP scores result in
similar perinatal outcomes as with weekly CST .
 Biophysical Parameters
2/8/2024 Seminar presentation on FGR 34
Cont…
four components of the BPP are lost at different levels of
hypoxemia and acidemia .
Loss of heart rate reactivity along with the absence of fetal
breathing.
decreased fetal tone and movement in association with more
advanced acidemia , hypoxemia, and hypercapnia.
2/8/2024 Seminar presentation on FGR 35
Cont…
 Doppler Ultrasound
Doppler parameters are influenced by several variables that
include vascular histology, tone, and fetal BP.

Early responses to placental insufficiency mild placental
vascular disease when UA EDV is still present ….Decrease in
CPR is compensatory.
2/8/2024 Seminar presentation on FGR 36
Cont…
Late responses to placental insufficiency are observed when
loss or reversal of UA EDV occurred in parallel with venous
Doppler indices.
Fetal Doppler assessment based on the UA alone is no
longer appropriate, particularly in the setting of early-onset
FGR prior to 34 weeks.
The SMFM does not recommend Doppler assessment of
the MCA or ductus venosus (DV) in the clinical
management of FGR, which is a significant difference
from the ISUOG guideline.
2/8/2024 Seminar presentation on FGR 37
Anticipation of progression
2/8/2024 Seminar presentation on FGR 38
Cont…
There is currently no treatment for FGR, and the management
and its outcomes relies on
 early diagnosis
 possible risk and etiologic identification
 optimal fetal surveillance
 timely delivery
 short term and long term complication prevention, identification
and intervention
 prevention
 Antenatally undetected SGA neonates had a 4-fold risk of
adverse outcome
It has been reported that a suboptimal antenatal management is
the most common finding in cases of unexplained stillborns
2/8/2024 Seminar presentation on FGR
Timing and Mode of Delivery
2/8/2024 Seminar presentation on FGR 40
Cont…
 The decision for delivery is a delicate balance between the risk of
prematurity and perinatal death
The timing of delivery in FGR is determined by
 a gestational age
 Severity of FGR
 Findings of fetal monitoring tests
 Maternal factors such as pre-eclampsia

 In SGA fetuses that remain undelivered after 38 weeks, the risk of
stillbirth doubles every week and reaches 60/10 000 for pregnancies
that continue beyond the due date.
 Steroid and magnesium sulfate adminstration protocol for preterm
FGR fetus is similar as non-IUGR .
2/8/2024 Seminar presentation on FGR
Cont…
2/8/2024 Seminar presentation on FGR
Risk of fetal death in
growth-restricted
fetuses with umbilical
and/or ductus venosus
absent or reversed end-
diastolic velocities
before 34 weeks of
gestation:
Cont…
 In IUGR with an UA Doppler S/D, RI or PI above than the 95th
percentile but without A/REDV or in the setting of severe FGR ,
delivery is recommended at 37 weeks of gestation
Delivery is recommended at 38–39 weeks in IUGR with an
EFW between 3rd and 10th percentile and normal UA Doppler
 Delivery is at 34 0/7–37 6/7 wks for IUGR with
oligohydramnios
 In the presence of AEDV, delivery is recommended at 33 0/7 to
34 0/7 wks
 In the presence of REDV, delivery is recommended at 30 0/7–
32 0/7 wks
2/8/2024 Seminar presentation on FGR
Cont…
 FGR in itself is not an indication for cesarean section. However,
primary cesarean section may be considered in selected cases of
severe FGR where the likelihood of successful vaginal delivery is low.
 Mode of delivery depends on
 gestational age
 severity of FGR
 Doppler changes
 associated obstetric complications
 parity
 cervical Bishop score, and patient preference
 Cesarean delivery should be considered in pregnancies with FGR
complicated by A/REDV
2/8/2024 Seminar presentation on FGR
Cont…
The optimal approach for cervical ripening in women
undergoing induction for FGR remains unclear
Cervical ripening using mechanical methods seem to be
associated with a lower rate of overall composite adverse
intrapartum outcome, cesarean section for non-reassuring
fetal heart tracing, uterine tachysystole and compared with
prostaglandins.
During labor, continuous FHR monitoring is recommended.
Delivery should take place at an institution with the
appropriate level of neonatal care for the gestational age.
2/8/2024 Seminar presentation on FGR
Monitoring, Timing, and Mode of Delivery in cases with FGR
2/8/2024 Seminar presentation on FGR
Delivery criteria for FGR
2/8/2024 Seminar presentation on FGR 47
Outcomes
Short-Term Outcomes
MAS
Hypoglycemia
Hypocalcemia
Hyponatremia
Polycythemia or anemia,
Thrombocytopenia
Hypothermia
Perinatal death
Long-Term Outcomes
Lag in growth
Poor school performance
Metabolic syndrome
Obesity
Diabetes
Stroke
 Coronary artery disease
2/8/2024 Seminar presentation on FGR 48
Fetal growth restriction in twin
gestations
Twin fetuses grow more slowly than singletons,
starting from 28–32 weeks.
At term, approximately 30%–50% of twins would be
identified as SGA.
The mechanisms underlying the relative smallness of
twins remain unclear
2/8/2024 Seminar presentation on FGR 49
Cont…
Two different beliefs
Pathologic
 Failure of the uteroplacental circulation to meet the demands of
two fetuses
Physiologic
 Benign physiological adaptation of twins to the “crowded”
intrauterine environment in an effort to delay the onset of labor
2/8/2024 Seminar presentation on FGR 50
Cont…
Growth abnormalities in twins manifest in 3 ways
Selective fetal growth restriction
Both twins small for GA
One twin significantly smaller (although neither is SGA )
2/8/2024 Seminar presentation on FGR 51
Causes of Discordant growth
Dichorionic twins Monochorionic twins
 Different genetic growth
potential
 Suboptimal implantation site of
one
 Umbilical cord abnormalities
such as velamentous insertion,
marginal insertion, or vasa
previa
 Placental pathology
 Unequally shared placenta
 Placental anastomosis as in
TTTS leads to perfusion
imbalance.
 Discordance in structural
anomalies
2/8/2024 Seminar presentation on FGR 52
Cont…
Twin gestations with discordant growth between two fetuses
that are appropriately grown for gestational age are not at
increased risk.
However, accumulated data suggest that weight discordancy
exceeding 25 to 30 percent most accurately predicts an adverse
perinatal outcome
Some diagnose sFGR when AC measurement difference
exceeds 20 mm or if fetal-growth discordance is >20 %
2/8/2024 Seminar presentation on FGR 53
Cont…
In dichorionic twin FGR is generally managed as in
singleton.
Determination of Couse , serial ultrasound evaluation,
Ongoing evaluation of fetal well being…
And timed delivery based on combination of factors ( GA,
UA doppler , BPP , …
2/8/2024 Seminar presentation on FGR 54
Selective FGR In MC twins
 Selective FGR is defined as growth restriction of one twin, with appropriate
growth in the co-twin .
 Diagnosed when EFW on a sonographic scan of the growth-restricted twin
falls below the 10th percentile, while the other twin is appropriate for GA
 Occurs in 10% to 15% of MCDA gestations
 Occurs earlier and has different course
 Umbilical artery (UA) Doppler findings cannot be interpreted in the same
way as in singleton or DC gestations
 sFGR can be seen more often in MCDA pregnancies than in MCMA
pregnancies
2/8/2024 Seminar presentation on FGR 55
Classification
Type I; is characterized by positive diastolic flow
 Commonest form with incidence of 29–63.5%
 A smaller degree of weight discordance
 Relatively benign clinical course.
Type II; by persistently absent or REDF
 carries a high risk of deterioration and demise.
 incidence: 22.4–36.5% of the sFGR
Type III; by intermittently absent or REDF
 incidence is 48% of all sFGR cases
 lower risk of deterioration than type II.
2/8/2024 Seminar presentation on FGR 56
Cont…
2/8/2024 Seminar presentation on FGR 57
Cont…
 There is no evidence of optimal monitoring of MC twins with sFGR .
 Serial evaluation of fetal growth is performed every 3 weeks
 If sFGR is diagnosed, biweekly testing of fetal wellbeing, evaluation
of AFV , and UA Doppler are undertaken for type II and III
 Doppler studies in the smaller fetus may help guide management.
2/8/2024 Seminar presentation on FGR 58
Cont…
Three management options are available for type II and III early-
onset sIUGR in a MC twin pregnancy:
Careful expectant management with an effort to maximize
outcome for both twins
Cord occlusion of the IUGR twin and
Laser photocoagulation for severe sFGR at early gestation and
where sFGR is combined with TTTS ( dichorionizing )
2/8/2024 Seminar presentation on FGR 59
References
1. Williams OBSTETRICS 26TH EDITION, PP. 2116-2141
2. Gabbe: Obstetrics: Normal and Problem Pregnancies, 8th ed. PP. 555-582
3. ACOG Practice Bulletin , Fetal growth restriction, No. 204, 2023
4. The Investigation and Management of the Small–for–Gestational–Age Fetus. Green-
top Guideline No. 31,MAY 2022
5. Best practice advice for screening, diagnosis, and management of fetal growth
restriction.FIGO, 2021
6. Diagnosis and management of small-for-gestational-age fetus and fetal growth
restriction, ISUOG Practice Guidelines: 2020
7. The High-Risk Profile of Selective Growth Restriction in Monochorionic Twin
Pregnancies, Medicina , 2023
8. Early onset fetal growth restriction, Maternal Health, Neonatology, and Perinatology,
2017
9. Fetal Growth (Restricted), South Australian Perinatal Practice Guideline, 2023
10. Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus
absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic
review and meta-analysis.https://doi.org/10.1016/j.ajog.2017.11.566
11. Diagnosis and management of fetal growth restriction: the SMFM guideline and comparison
with the ISUOG guideline, Ultrasound Obstet Gynecol 2021; 57: 880–883
2/8/2024 Seminar presentation on FGR 60
2/8/2024 Seminar presentation on FGR 61

More Related Content

Similar to Seminar Presentation on fetal growth restriction

Low birthweight delivery prevalence and associated factors as seen at a terti...
Low birthweight delivery prevalence and associated factors as seen at a terti...Low birthweight delivery prevalence and associated factors as seen at a terti...
Low birthweight delivery prevalence and associated factors as seen at a terti...
Michael Olafusi
 

Similar to Seminar Presentation on fetal growth restriction (20)

Intrauterine growth restriction
Intrauterine growth restrictionIntrauterine growth restriction
Intrauterine growth restriction
 
IUGR.pptx
IUGR.pptxIUGR.pptx
IUGR.pptx
 
Jc aprile 2017
Jc aprile 2017Jc aprile 2017
Jc aprile 2017
 
RPL.pptx
RPL.pptxRPL.pptx
RPL.pptx
 
Diagnosis and surveillance of late onset fetal growth restriction 2018
Diagnosis and surveillance of late onset fetal growth restriction 2018Diagnosis and surveillance of late onset fetal growth restriction 2018
Diagnosis and surveillance of late onset fetal growth restriction 2018
 
Manejo de embarazo a termino tardio y postermino
Manejo de embarazo a termino tardio y posterminoManejo de embarazo a termino tardio y postermino
Manejo de embarazo a termino tardio y postermino
 
Overview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy LossOverview of Recurrent Pregnancy Loss
Overview of Recurrent Pregnancy Loss
 
Trastornos del crecimiento fetal. Definición, causas y clasificación del CIR....
Trastornos del crecimiento fetal. Definición, causas y clasificación del CIR....Trastornos del crecimiento fetal. Definición, causas y clasificación del CIR....
Trastornos del crecimiento fetal. Definición, causas y clasificación del CIR....
 
IUGR
IUGRIUGR
IUGR
 
approach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survellianceapproach to evidence based antenatal Fetal survelliance
approach to evidence based antenatal Fetal survelliance
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
 
Prenatal diagnosis
Prenatal diagnosis Prenatal diagnosis
Prenatal diagnosis
 
Fetal Growth Restriction.pptx
Fetal Growth Restriction.pptxFetal Growth Restriction.pptx
Fetal Growth Restriction.pptx
 
Low birthweight delivery prevalence and associated factors as seen at a terti...
Low birthweight delivery prevalence and associated factors as seen at a terti...Low birthweight delivery prevalence and associated factors as seen at a terti...
Low birthweight delivery prevalence and associated factors as seen at a terti...
 
Gestational Trophobalstic Disease
Gestational Trophobalstic DiseaseGestational Trophobalstic Disease
Gestational Trophobalstic Disease
 
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
Genetic testing
Genetic testingGenetic testing
Genetic testing
 
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptxDilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
Dilemmas in Diagnosis and Management of FGR Dr NNC 06082022.pptx
 
Clinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreClinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centre
 
IUGR PPT.pptx
IUGR PPT.pptxIUGR PPT.pptx
IUGR PPT.pptx
 

Recently uploaded

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th Edition by ...
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
5Cladba ADBB 5cladba buy 6cl adbb powder 5cl ADBB precursor materials
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 

Seminar Presentation on fetal growth restriction

  • 1. Presenter: Dr Abdulaziz N .(Year II resident) Moderator: Dr Jemal (Ass. Professor of gyneobs ) 2/8/2024 Seminar presentation on FGR 1
  • 2. Outline  Objective Introduction Definition and pattern of FGR Etiologies of FGR Diagnostic Tools in FGR Screening And prevention Management of FGR Selective FGR References 2/8/2024 Seminar presentation on FGR
  • 3. Objectives To discuss on definition and Diagnosis FGR To discuss on Etiologies and risk factors FGR To discuss on methods of screening and prevention of FGR To discuss current on recommendations on management of FGR To discuss on Diagnosis and management of selective FGR 2/8/2024 Seminar presentation on FGR
  • 4. Introduction Fetal growth may be divided into three phases phase of hyperplasia ( First 16 weeks ) Phase of cellular hyperplasia and hypertrophy ( 16-32 weeks) Phase of cellular hypertrophy (After 32 weeks ) Eighty percent of fetal fat gain is accrued after 28 weeks’ gestation 2/8/2024 Seminar presentation on FGR 4
  • 5. Cont… Fetal development is believed to be determined by maternal provision of substrate and its placental transfer, whereas fetal growth potential is governed by the genome. FGR is defined as the failure of the fetus to meet its growth potential due to a pathological factor. 2/8/2024 Seminar presentation on FGR 5
  • 6. Cont… FGR is the second leading cause of PNM (6-10x ) next to prematurity 53% of preterm stillbirths and 26% of term stillbirths have FGR. The incidence of intrapartum asphyxia may be as high as 50% 2/8/2024 Seminar presentation on FGR 6
  • 7. Definition and pattern of FGR From the 1960s, growth has been classified by the absolute birth weight as ; LBW; <2500 g VLBW; < 1500 g ELBW; <1000 g macrosomia > 4000 g subsequently, studies demonstrated only the comparison actual birthweight with GA, associated with high risk. 2/8/2024 Seminar presentation on FGR 7
  • 8. Cont… This resulted in the currently accepted classification of birth weight as; very small for gestational age (VSGA; <3rd percentile), small for gestational age (SGA; <10th percentile),  Average for gestational age (AGA; 10th to 90th percentile), or  Large for gestational age (LGA; >90th percentile). 2/8/2024 Seminar presentation on FGR 8
  • 9. ETIOLOGIES AND RISK FACTORS FGR Maternal Fetal  Hypertensive Disease  Pregestational diabetes  Cyanotic cardiac disease  Autoimmune disease  Restrictive pulmonary disease  High altitude  Substance abuse  Malabsorbative disease  Malnutrition  Multiple gestation  Teratogenic exposure  Fetal infection  Genetic Disorders  Structural abnormalities placental  Primary placental disease  Placental abruption and ind infarction  Placenta previa  Placental mosaicism 2/8/2024 Seminar presentation on FGR 9
  • 10. Diagnostic Tools in FGR  Accurate gestational age assessment is critical for determining whether birth weight is normal.  Symphysis–fundal height  A single SFH at 32-34ks has 65-85 % sensitivity and 96% specificity  The overall sensitivity of serial fundal height to detect FGR ranges from 11 to 25 % .  Detection rates are lower in obese women 2/8/2024 Seminar presentation on FGR 10
  • 11. Diagnostic Tools in FGR Fetal Biometry SEFW- most important calculated US variable BPD-alone is a poor tool for the detection of FGR HC TCD AC-single best measurement for the detection of FGR HC/AC -70% to 85% FGRs detected FL/AC ≥ 23.5 suggests FGR 2/8/2024 Seminar presentation on FGR 11
  • 12. Diagnostic Tools…. Fetal Anatomic Survey Amniotic Fluid Assessment -Placental dysfunction and fetal hypoxemia both may result in decreased perfusion of the fetal kidneys. 2/8/2024 Seminar presentation on FGR 12
  • 13. Diagnostic Tools… Doppler Velocimetry –  serves as a diagnostic as well as a monitoring tool  Arterial Doppler waveforms provide information on downstream vascular resistance.  S/D ratio, the resistance index, and the pulsatility index (PI) are the three Doppler indices most widely used  Venous Doppler parameter Provide assessment of cardiac forward function 2/8/2024 Seminar presentation on FGR 13
  • 14. Umbilical Artery Flow-Velocity Waveforms ►Normal ►Decreased EDF; Indices become affected when 30% of placental bed obliterated ►AEDF-when 50% of placental bed obliterated ►REDF-when ≥70% of placental bed obliterated 2/8/2024 Seminar presentation on FGR
  • 15. Cont… Invasive Testing maternal serology and/or viral polymerase chain reaction (PCR) Invasive fetal testing can be performed to obtain amniotic fluid and/or fetal blood for karyotyping or microarray analysis 2/8/2024 Seminar presentation on FGR 15
  • 16. Fetal Growth Restriction Dx Various criteria has been used to define FGR. Included; EFW below the 3rd, 5th, or 10th percentiles ; Similar abdominal circumference (AC) percentiles; A specified decline in the EFW percentile or AC percentile over serial assessments; and Various abnormal Doppler findings 2/8/2024 Seminar presentation on FGR 16
  • 17. Diagnosis SMFM-ACOG-AIUM ISUOG AC or EFW <10th centile for GA Early (<32 weeks) Late (≥32 weeks) AC or EFW <3rd centile for GA or UA-AEDF or AC or EFW <10th centile Combined with one of the following: a) UtA PI >95th centile b) UA-PI >95th centile AC or EFW <3rd centile for GA or Any two of the following: a) AC or EFW <10th centile for GA b) AC/EFW crossing centiles >2 quartiles on growth centiles c) CPR <5th centile or UA-PI >95th centile 2/8/2024 Seminar presentation on FGR 17
  • 18. Cont.. SMFM criteria had higher sensitivity than the ISUOG criteria for the prediction of neonatal SGA (54.7% vs 28.8%) but had a higher false-positive rate (6.7% vs 1.6%). The positive predictive value for the prediction of neonatal morbidity was poor for both definitions (15.3% vs 25.5%) SMFM criteria offers a more simple, straightforward and pragmatic approach to the diagnosis of FGR, that also has the ability to identify more at-risk pregnancies. 2/8/2024 Seminar presentation on FGR 18
  • 19. Cont… Early Onset FGR Late Onset FGR  <32 weeks  prevalence of 0.5%_1%  Strong association with PE  Predictable natural course  Main challenge is management  ≥ 32 weeks  5%_10%  Less likely associated with PE  Main challenge is diagnosis  Natural course is less predictable and there is a risk of sudden decompensation And stillbirth. 2/8/2024 Seminar presentation on FGR 19
  • 20. Which growth chart should should be used Growth references vs growth standards Charts based on birth weight vs SFWE Universal versus customized charts 2/8/2024 Seminar presentation on FGR 20 Comparison of the 10th percentile curves of common growth charts.
  • 21. Diagnostic Algorism 2/8/2024 Seminar presentation on FGR 21
  • 22. Screening And prevention FGR as a disease entity fulfills several criteria that potentially justify a screening program.  Maternal History poor pregnancy outcome (spontaneous abortions , neonatal and intrauterine deaths)  25 % risk of recurrence after 1 FGR.  After 2 pregnancies the risk increased by 4 fold. 2/8/2024 Seminar presentation on FGR 22
  • 23. Maternal serum analytes Serum estriol, human placental lactogen , hCG and MSAFP in 2nd Triminister . Elevated MSAFP and hCG levels in the 2nd trimester are considered markers of abnormal placentation. Associated with increased risk of FGR Single, unexplained elevated value of 2 to 2.5 MoM raises the risk 5-fold to 10-fold. 2/8/2024 Seminar presentation on FGR 23
  • 24. Cont… A decrease in PAPP-A or the PlGF shown the most consistent predictive performance in 1st triminister. They associated with early abnormalities in placental angiogenesis and development  A decrease in the PAPP-A to less than 0.8 MoM is a risk for subsequent placental dysfunction 2/8/2024 Seminar presentation on FGR 24
  • 25. Cont…  Clinical Examination After 20 weeks’ gestation, a lag of the SFH ≥4 cm signifies FGR Is the only screening tool recommended  Maternal Doppler Velocimetry Abnormal uterine artery flow-velocity waveforms  Integrated Approach 2/8/2024 Seminar presentation on FGR 25
  • 26. prevention Efforts to prevent FGR have been disappointing Life style modification Low-dose aspirin has been extensively evaluated as a possible preventive agent for placental dysfunction. Only starting aspirin before 16 weeks’ gestation derive a 50% to 60% reduction in the RR for development of preeclampsia or FGR. 2/8/2024 Seminar presentation on FGR 26
  • 27. Cont… Elimination of contributors such as stress, smoking, and alcohol and drug use .  Bed rest in the left lateral decubitus position to increase placental blood flow. Dietary supplementation may be helpful in those with poor weight gain or low pre pregnancy weight 2/8/2024 Seminar presentation on FGR 27
  • 28. Cont… Maternal hyper oxygenation can raise the fetal cord blood pO2 fetal growth velocity was not improved  Maternal hyper alimentation Maternal volume expansion Corticosteroids for enhancing lung maturation and preventing IVH when delivery is anticipated before 34 weeks’ gestation 2/8/2024 Seminar presentation on FGR 28
  • 29. Risk Assessment and Screening for FGR 2/8/2024 Seminar presentation on FGR 29
  • 30. Assessment of fetal well-being The institution of antenatal surveillance is a critical component in the management of the growth-restricted fetus. The goal is to avoid stillbirth and optimize the timing of delivery, The likelihood of fetal acidemia and stillbirth is the strongest fetal criterion for delivery. Incontrast, gestational age–specific expectations for neonatal complications and survival force conservative management. 2/8/2024 Seminar presentation on FGR 30
  • 31. Cont…  Antenatal surveillance tests need to predict fetal acid-base status, rate of anticipated progression, and the resulting risk for deterioration and stillbirth. The monitoring tools available to achieve this include NST , CST, BPP and Doppler studies. 2/8/2024 Seminar presentation on FGR 31
  • 32. Cont…  Maternal Monitoring of Fetal Activity Fetal activity charting in pregnancies complicated by FGR predicts subsequent distress in labor.  Fetal Heart Rate Analysis Normal FHR characteristics are determined by gestational age, maturational and functional status of central regulatory centers, and oxygen tension 2/8/2024 Seminar presentation on FGR 32
  • 33. Cont… Reactive NST indicates absence of fetal acidemia at the moment of the FHR recording Correlates highly with a fetus not in immediate danger of intrauterine demise Nonreactive NST results, on the other hand, are often falsely positive and require further evaluation The CST is an additional option for testing placental respiratory reserve 2/8/2024 Seminar presentation on FGR 33
  • 34. Cont…  Amniotic Fluid Volume  Assessment of AFV provides an indirect measure of vascular status Interventions based on twice-weekly MBPP scores result in similar perinatal outcomes as with weekly CST .  Biophysical Parameters 2/8/2024 Seminar presentation on FGR 34
  • 35. Cont… four components of the BPP are lost at different levels of hypoxemia and acidemia . Loss of heart rate reactivity along with the absence of fetal breathing. decreased fetal tone and movement in association with more advanced acidemia , hypoxemia, and hypercapnia. 2/8/2024 Seminar presentation on FGR 35
  • 36. Cont…  Doppler Ultrasound Doppler parameters are influenced by several variables that include vascular histology, tone, and fetal BP.  Early responses to placental insufficiency mild placental vascular disease when UA EDV is still present ….Decrease in CPR is compensatory. 2/8/2024 Seminar presentation on FGR 36
  • 37. Cont… Late responses to placental insufficiency are observed when loss or reversal of UA EDV occurred in parallel with venous Doppler indices. Fetal Doppler assessment based on the UA alone is no longer appropriate, particularly in the setting of early-onset FGR prior to 34 weeks. The SMFM does not recommend Doppler assessment of the MCA or ductus venosus (DV) in the clinical management of FGR, which is a significant difference from the ISUOG guideline. 2/8/2024 Seminar presentation on FGR 37
  • 38. Anticipation of progression 2/8/2024 Seminar presentation on FGR 38
  • 39. Cont… There is currently no treatment for FGR, and the management and its outcomes relies on  early diagnosis  possible risk and etiologic identification  optimal fetal surveillance  timely delivery  short term and long term complication prevention, identification and intervention  prevention  Antenatally undetected SGA neonates had a 4-fold risk of adverse outcome It has been reported that a suboptimal antenatal management is the most common finding in cases of unexplained stillborns 2/8/2024 Seminar presentation on FGR
  • 40. Timing and Mode of Delivery 2/8/2024 Seminar presentation on FGR 40
  • 41. Cont…  The decision for delivery is a delicate balance between the risk of prematurity and perinatal death The timing of delivery in FGR is determined by  a gestational age  Severity of FGR  Findings of fetal monitoring tests  Maternal factors such as pre-eclampsia   In SGA fetuses that remain undelivered after 38 weeks, the risk of stillbirth doubles every week and reaches 60/10 000 for pregnancies that continue beyond the due date.  Steroid and magnesium sulfate adminstration protocol for preterm FGR fetus is similar as non-IUGR . 2/8/2024 Seminar presentation on FGR
  • 42. Cont… 2/8/2024 Seminar presentation on FGR Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end- diastolic velocities before 34 weeks of gestation:
  • 43. Cont…  In IUGR with an UA Doppler S/D, RI or PI above than the 95th percentile but without A/REDV or in the setting of severe FGR , delivery is recommended at 37 weeks of gestation Delivery is recommended at 38–39 weeks in IUGR with an EFW between 3rd and 10th percentile and normal UA Doppler  Delivery is at 34 0/7–37 6/7 wks for IUGR with oligohydramnios  In the presence of AEDV, delivery is recommended at 33 0/7 to 34 0/7 wks  In the presence of REDV, delivery is recommended at 30 0/7– 32 0/7 wks 2/8/2024 Seminar presentation on FGR
  • 44. Cont…  FGR in itself is not an indication for cesarean section. However, primary cesarean section may be considered in selected cases of severe FGR where the likelihood of successful vaginal delivery is low.  Mode of delivery depends on  gestational age  severity of FGR  Doppler changes  associated obstetric complications  parity  cervical Bishop score, and patient preference  Cesarean delivery should be considered in pregnancies with FGR complicated by A/REDV 2/8/2024 Seminar presentation on FGR
  • 45. Cont… The optimal approach for cervical ripening in women undergoing induction for FGR remains unclear Cervical ripening using mechanical methods seem to be associated with a lower rate of overall composite adverse intrapartum outcome, cesarean section for non-reassuring fetal heart tracing, uterine tachysystole and compared with prostaglandins. During labor, continuous FHR monitoring is recommended. Delivery should take place at an institution with the appropriate level of neonatal care for the gestational age. 2/8/2024 Seminar presentation on FGR
  • 46. Monitoring, Timing, and Mode of Delivery in cases with FGR 2/8/2024 Seminar presentation on FGR
  • 47. Delivery criteria for FGR 2/8/2024 Seminar presentation on FGR 47
  • 48. Outcomes Short-Term Outcomes MAS Hypoglycemia Hypocalcemia Hyponatremia Polycythemia or anemia, Thrombocytopenia Hypothermia Perinatal death Long-Term Outcomes Lag in growth Poor school performance Metabolic syndrome Obesity Diabetes Stroke  Coronary artery disease 2/8/2024 Seminar presentation on FGR 48
  • 49. Fetal growth restriction in twin gestations Twin fetuses grow more slowly than singletons, starting from 28–32 weeks. At term, approximately 30%–50% of twins would be identified as SGA. The mechanisms underlying the relative smallness of twins remain unclear 2/8/2024 Seminar presentation on FGR 49
  • 50. Cont… Two different beliefs Pathologic  Failure of the uteroplacental circulation to meet the demands of two fetuses Physiologic  Benign physiological adaptation of twins to the “crowded” intrauterine environment in an effort to delay the onset of labor 2/8/2024 Seminar presentation on FGR 50
  • 51. Cont… Growth abnormalities in twins manifest in 3 ways Selective fetal growth restriction Both twins small for GA One twin significantly smaller (although neither is SGA ) 2/8/2024 Seminar presentation on FGR 51
  • 52. Causes of Discordant growth Dichorionic twins Monochorionic twins  Different genetic growth potential  Suboptimal implantation site of one  Umbilical cord abnormalities such as velamentous insertion, marginal insertion, or vasa previa  Placental pathology  Unequally shared placenta  Placental anastomosis as in TTTS leads to perfusion imbalance.  Discordance in structural anomalies 2/8/2024 Seminar presentation on FGR 52
  • 53. Cont… Twin gestations with discordant growth between two fetuses that are appropriately grown for gestational age are not at increased risk. However, accumulated data suggest that weight discordancy exceeding 25 to 30 percent most accurately predicts an adverse perinatal outcome Some diagnose sFGR when AC measurement difference exceeds 20 mm or if fetal-growth discordance is >20 % 2/8/2024 Seminar presentation on FGR 53
  • 54. Cont… In dichorionic twin FGR is generally managed as in singleton. Determination of Couse , serial ultrasound evaluation, Ongoing evaluation of fetal well being… And timed delivery based on combination of factors ( GA, UA doppler , BPP , … 2/8/2024 Seminar presentation on FGR 54
  • 55. Selective FGR In MC twins  Selective FGR is defined as growth restriction of one twin, with appropriate growth in the co-twin .  Diagnosed when EFW on a sonographic scan of the growth-restricted twin falls below the 10th percentile, while the other twin is appropriate for GA  Occurs in 10% to 15% of MCDA gestations  Occurs earlier and has different course  Umbilical artery (UA) Doppler findings cannot be interpreted in the same way as in singleton or DC gestations  sFGR can be seen more often in MCDA pregnancies than in MCMA pregnancies 2/8/2024 Seminar presentation on FGR 55
  • 56. Classification Type I; is characterized by positive diastolic flow  Commonest form with incidence of 29–63.5%  A smaller degree of weight discordance  Relatively benign clinical course. Type II; by persistently absent or REDF  carries a high risk of deterioration and demise.  incidence: 22.4–36.5% of the sFGR Type III; by intermittently absent or REDF  incidence is 48% of all sFGR cases  lower risk of deterioration than type II. 2/8/2024 Seminar presentation on FGR 56
  • 58. Cont…  There is no evidence of optimal monitoring of MC twins with sFGR .  Serial evaluation of fetal growth is performed every 3 weeks  If sFGR is diagnosed, biweekly testing of fetal wellbeing, evaluation of AFV , and UA Doppler are undertaken for type II and III  Doppler studies in the smaller fetus may help guide management. 2/8/2024 Seminar presentation on FGR 58
  • 59. Cont… Three management options are available for type II and III early- onset sIUGR in a MC twin pregnancy: Careful expectant management with an effort to maximize outcome for both twins Cord occlusion of the IUGR twin and Laser photocoagulation for severe sFGR at early gestation and where sFGR is combined with TTTS ( dichorionizing ) 2/8/2024 Seminar presentation on FGR 59
  • 60. References 1. Williams OBSTETRICS 26TH EDITION, PP. 2116-2141 2. Gabbe: Obstetrics: Normal and Problem Pregnancies, 8th ed. PP. 555-582 3. ACOG Practice Bulletin , Fetal growth restriction, No. 204, 2023 4. The Investigation and Management of the Small–for–Gestational–Age Fetus. Green- top Guideline No. 31,MAY 2022 5. Best practice advice for screening, diagnosis, and management of fetal growth restriction.FIGO, 2021 6. Diagnosis and management of small-for-gestational-age fetus and fetal growth restriction, ISUOG Practice Guidelines: 2020 7. The High-Risk Profile of Selective Growth Restriction in Monochorionic Twin Pregnancies, Medicina , 2023 8. Early onset fetal growth restriction, Maternal Health, Neonatology, and Perinatology, 2017 9. Fetal Growth (Restricted), South Australian Perinatal Practice Guideline, 2023 10. Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis.https://doi.org/10.1016/j.ajog.2017.11.566 11. Diagnosis and management of fetal growth restriction: the SMFM guideline and comparison with the ISUOG guideline, Ultrasound Obstet Gynecol 2021; 57: 880–883 2/8/2024 Seminar presentation on FGR 60